Abstract:2-Hydroxy fatty acids (2-OHFAs) and 3-hydroxy fatty acids (3-OHFAs) with the same carbon backbone are isomers, both of which are closely related to diseases involving fatty acid oxidation disorder. However, the comprehensive profiling of 2- and 3-OHFAs remains an ongoing challenge due to their high structure similarity, few structure-informative product ions, and limited availability of standards. Here, we developed a new strategy to profile and identify 2- and 3-OHFAs according to structure-dependent retention time prediction models using ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Both accurate MS and MS/MS spectra were collected for peak annotation by comparison with an in-house database of theoretically possible 2- and 3-OHFAs. The structures were further confirmed by the validated structure-dependent retention time prediction models, taking advantage of the correlation between the retention time, carbon chain length and number of double bonds, as well as the hydroxyl position-induced isomeric retention time shift rule. With the use of this strategy, 18 2-OHFAs and 32 3-OHFAs were identified in the pooled plasma, of which 7 2-OHFAs and 20 3-OHFAs were identified for the first time in this work, furthering our understanding of OHFA metabolism. Subsequent quantitation method was developed by scheduled multiple reaction monitoring (MRM) and then applied to investigate the alteration of 2 - and 3-OHFAs in esophageal squamous cell carcinoma (ESCC) patients. Finally, a potential biomarker panel consisting of six OHFAs with good diagnostic performance was achieved. Our study provides a new strategy for isomer identification and analysis, showing great potential for targeted metabolomics in dinical biomarker discovery.

Lipid profiling of human plasma from peritoneal dialysis patients using an improved 2D (NP/RP) LC-QToF MS method

Lipid profiling of rat peritoneal surface layers by online normal- and reversed-phase 2D LC QToF-MS

A Novel Online Two-Dimensional Supercritical Fluid Chromatography/reversed Phase Liquid Chromatography–mass Spectrometry Method for Lipid Profiling

Quantitative determination of lysophosphatidic acid by LC/ESI/MS/MS employing a reversed phase HPLC column.

A Not-Stop-Flow Online Normal-/Reversed-Phase Two-Dimensional Liquid Chromatography-Quadrupole Time-Of-Flight Mass Spectrometry Method for Comprehensive Lipid Profiling of Human Plasma from Atherosclerosis Patients

High Throughput LC-MS Platform for Large Scale Screening of Bioactive Polar Lipids in Human Plasma and Serum

Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography-mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy.

Strategy for characterization and quantification of fatty acids in plasma by parallel d 0 /d 6 -dansylhydrazine derivatization combined with UPLC–MS/MS

Rapid profiling and quantification of phospholipid molecular species in human plasma based on chemical derivatization coupled with electrospray ionization tandem mass spectrometry

Development of Method for Serum Preparation and Lipidomics Analysis Based on Rapid Resolution Liquid Chromatography-Mass Spectrometry

Post Acquisition Data Processing Techniques for Lipid Analysis by Quadrupole Time-Of-Flight Mass Spectrometry

Four-dimensional trapped ion mobility spectrometry lipidomics for high throughput clinical profiling of human blood samples

Use of Liquid Chromatography/tandem Mass Spectrometry and Online Databases for Identification of Phosphocholines and Lysophosphatidylcholines in Human Red Blood Cells

Phospholipids Profiling and Outcome of Peritoneal Dialysis Patients

High-throughput and in-depth analysis of plasma proteome by UV-assisted protein digestion, 5-plex labeling and MS-based high abundance protein removal method

Strategy for Global Profiling and Identification of 2- and 3-Hydroxy Fatty Acids in Plasma by UPLC-MS/MS.

High Throughput Screening of Lipid Metabolites in Blood Based on the Data-independent Acquisition Mode

A plasma lipidomics strategy reveals perturbed lipid metabolic pathways and potential lipid biomarkers of human colorectal cancer.

Simultaneous determination and quantification of seven major phospholipid classes in human blood using normal-phase liquid chromatography coupled with electrospray mass spectrometry and the application in diabetes nephropathy.

Plasma Metabolomics Profiling of Maintenance Hemodialysis Based on Capillary Electrophoresis - Time of Flight Mass Spectrometry

Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis.